Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

The Canadian Bioceutical CBICF

MPX Bioceutical Corp is a Canada based company involved in the natural health products industry. It is engaged in the manufacture and distribution of nutraceuticals to the North American marketplace and providing financial and business expertise to emerging corporations primarily in the pharmaceutical, medical and biotechnology industries. The company provides management, staffing, procurement, advisory, financial, real estate rental, logistics and administrative services to two medicinal cannab


GREY:CBICF - Post by User

Comment by blueboyon Aug 24, 2018 8:09pm
258 Views
Post# 28515907

RE:RE:Am I missing something about MPX??

RE:RE:Am I missing something about MPX??
MPX already HAS a cultivation license in Canada and the plants arrived last week at the site.  They need to get their Sales license still, but that takes a bit more time.  The license for Owen Sound is less important now that they bought Canveda.

The court case is a pain, to be sure, but Scott said on the last call that it was business as usual and that sales looked good.  I am not going to worry about the court case until we hear that MPX themselves are in trouble (which I doubt will happen).  Arizona has a nice little MJ lobby going on, and they will work to get this sorted out.

Revenues next week should be great, up quite a bit from Q4's $8 million (which was up a lot from  Q3's $4.5 million).  That kind of growth is astounding, and is far and away better than any LP is getting in Canada (in Medical) right now (including the big boys).

If revenues are as expected next week, I expect a nice jump in MPX, to put them back in line with the valuations of other US-based MJ stocks.

BB
<< Previous
Bullboard Posts
Next >>